In CLL patients, disruption in oscillation was restricted to Per2, Rev-ERBa and PPARa and oscillation of BMAL1, Cry2 and CLOCK was largely unaffected (Figure 4). This evidence concerns the gene CRY2 and B-cell chronic lymphocytic leukemia.